All News about Lexaria Bioscience Corp
![](https://cdn.benzinga.com/files/images/story/2023/03/02/louis.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking Forward to 2023 Goals for Patented DehydraTECH(TM) Technology
February 23, 2023
Topics
Economy
Exposures
Economy
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Findings from Hypertension Study
February 21, 2023
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Findings from Hypertension Study
February 21, 2023
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/images/story/2023/02/21/lexx_logo_light__d060d616e539309672291569e6228e67.png?width=1200&height=800&fit=crop)
Lexaria Discovers Potential Novel Mechanism From Hypertension Study Of Processed CBD
February 21, 2023
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.